Clinical Trial Update: Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

View source ↗

Summary

Clinical trial update describing ongoing recruitment for a national cohort study of patients with malignant melanoma (resectable stage II–IV or unresectable pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Malignant Melanoma | Status: RECRUITING